testosterone undecanoate has been researched along with Diabetes Mellitus, Type 2 in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 15 (75.00) | 24.3611 |
| 2020's | 3 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bracken, K; Conway, AJ; Desai, R; Grossmann, M; Handelsman, DJ; Inder, WJ; Jesudason, D; Ly, LP; Shankara-Narayana, N; Stuckey, BGA; Wittert, GA; Yeap, BB | 1 |
| Dandona, P; Dhindsa, S; Doros, G; Haider, A; Haider, KS; Hanefeld, M; Saad, F; Traish, A | 1 |
| Cole, N; Hackett, G; Jones, P; Ramachandran, S; Saghir, A; Strange, RC | 2 |
| Proshchai, GA; Vorokhobina, NV; Zagarskikh, EY | 1 |
| DI, HJ; Fan, YF; Liu, C; Liu, KM; Zhang, HF | 1 |
| Denisova, IA; Morgunov, LY; Rozhkova, TI; Skvortsova, VI; Stakhovskaya, LV | 1 |
| Allan, C; Atlantis, E; Bracken, K; Conway, A; Daniel, M; Gebski, V; Grossmann, M; Hague, W; Handelsman, DJ; Inder, W; Jenkins, A; Keech, A; McLachlan, R; Robledo, K; Stuckey, B; Wittert, G; Yeap, BB | 1 |
| Caliber, M; Doros, G; Garvey, WT; Haider, A; Haider, KS; Saad, F; Yassin, A | 1 |
| Bhartia, M; Cole, N; Hackett, G; Kennedy, D; Raju, J; Wilkinson, P | 2 |
| Mehtiyev, T | 1 |
| Bhartia, M; Cole, N; Hackett, G; Kennedy, D; Raju, J; Saghir, A; Wilkinson, P | 1 |
| Dupuis, P; Gianatti, EJ; Grossmann, M; Hoermann, R; Strauss, BJ; Wentworth, JM; Zajac, JD | 1 |
| Dupuis, P; Gianatti, EJ; Grossmann, M; Hoermann, R; Zajac, JD | 1 |
| Dupuis, P; Gianatti, EJ; Grossmann, M; Hoermann, R; Lam, Q; Zajac, JD | 1 |
| Carbone, MD; De Pergola, G; Giagulli, VA; Guastamacchia, E; Licchelli, B; Ramunni, MI; Sabbà, C; Triggiani, V | 1 |
| Denisova, IA; Morgunov, LIu; Rozhkova, TI; Skvortsova, VI; Stakhovskaia, LV | 1 |
| Boneva, Z; Boyanov, MA; Christov, VG | 1 |
| Gontcharov, NP; Kalinchenko, SY; Katsiya, GV; Kozlov, GI | 1 |
12 trial(s) available for testosterone undecanoate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injections.
Topics: Aged; Cohort Studies; Diabetes Mellitus, Type 2; Dihydrotestosterone; Follicle Stimulating Hormone; Follow-Up Studies; Genitalia, Male; Glucose Intolerance; Humans; Hypogonadism; Injections; Luteinizing Hormone; Male; Middle Aged; Quality of Life; Recovery of Function; Sexual Behavior; Testosterone; Withholding Treatment | 2022 |
Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diabetes Complications; Diabetes Mellitus, Type 2; Double-Blind Method; Hormone Replacement Therapy; Humans; Hypogonadism; Libido; Male; Middle Aged; Penile Erection; Testosterone; Young Adult | 2017 |
[Testosterone Undecanoate Pills improves insulin resistance in type-2 diabetes men with hypogonadism].
Topics: Androgens; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypogonadism; Insulin Resistance; Lipids; Male; Testosterone; Waist Circumference | 2017 |
Testosterone therapy to prevent type 2 diabetes mellitus in at-risk men (T4DM): Design and implementation of a double-blind randomized controlled trial.
Topics: Affect; Aged; Androgens; Body Composition; Diabetes Mellitus, Type 2; Double-Blind Method; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Hand Strength; Health Care Costs; Humans; Insulin; Lower Urinary Tract Symptoms; Male; Middle Aged; Obesity; Overweight; Patient Acceptance of Health Care; Testosterone; Weight Reduction Programs | 2019 |
Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.
Topics: Adult; Affect; Aged; Aged, 80 and over; Depression; Diabetes Mellitus, Type 2; Double-Blind Method; England; Erectile Dysfunction; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Middle Aged; Patient Satisfaction; Penile Erection; Phosphodiesterase 5 Inhibitors; Prospective Studies; Quality of Life; Sexual Behavior; Surveys and Questionnaires; Testosterone; Treatment Outcome | 2013 |
Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study.
Topics: Adult; Aged; Androgens; Body Composition; Body Mass Index; Delayed-Action Preparations; Depressive Disorder; Diabetes Mellitus, Type 2; Double-Blind Method; Erectile Dysfunction; Glycated Hemoglobin; Humans; Hypogonadism; Insulin Resistance; Male; Middle Aged; Obesity; Testosterone; Young Adult | 2014 |
The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
Topics: Adult; Aged; Aged, 80 and over; Androgens; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Humans; Hypoglycemic Agents; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Patient Satisfaction; Prospective Studies; Sexual Dysfunction, Physiological; Testosterone; Treatment Outcome | 2014 |
Effect of testosterone treatment on glucose metabolism in men with type 2 diabetes: a randomized controlled trial.
Topics: Abdominal Fat; Adult; Aged; Androgens; Blood Glucose; Carbohydrate Metabolism; Diabetes Mellitus, Type 2; Double-Blind Method; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Injections, Intramuscular; Insulin Resistance; Male; Middle Aged; Obesity; Testosterone | 2014 |
Effect of testosterone treatment on constitutional and sexual symptoms in men with type 2 diabetes in a randomized, placebo-controlled clinical trial.
Topics: Adult; Aged; Aging; Androgens; Depression; Diabetes Mellitus, Type 2; Double-Blind Method; Erectile Dysfunction; Hormone Replacement Therapy; Humans; Libido; Male; Middle Aged; Obesity; Placebos; Testosterone; Treatment Outcome | 2014 |
Effect of testosterone treatment on cardiac biomarkers in a randomized controlled trial of men with type 2 diabetes.
Topics: Adult; Aged; Biomarkers; Coronary Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Humans; Male; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Outcome Assessment, Health Care; Peptide Fragments; Prospective Studies; Risk Factors; Testosterone; Time Factors; Troponin T; United Kingdom | 2016 |
Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Androgens; Diabetes Complications; Diabetes Mellitus, Type 2; Double-Blind Method; Humans; Hypogonadism; Male; Middle Aged; Penile Erection; Severity of Illness Index; Sexuality; Testosterone; Time Factors; Young Adult | 2016 |
Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency.
Topics: Androgens; Blood Glucose; Body Composition; Diabetes Mellitus, Type 2; Erectile Dysfunction; Homeostasis; Hormone Replacement Therapy; Humans; Libido; Male; Middle Aged; Obesity; Testosterone | 2003 |
8 other study(ies) available for testosterone undecanoate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Humans; Hypogonadism; Male; Registries; Testosterone | 2020 |
[Fibroblast growth factor-21 as a marker of premature aging in young and middled-aged men with type 2 diabetes].
Topics: Adult; Aging, Premature; Androgens; Biomarkers; Diabetes Mellitus, Type 2; Early Diagnosis; Fibroblast Growth Factors; Humans; Male; Middle Aged; Surveys and Questionnaires; Testosterone | 2018 |
Hypogonadism and its treatment following ischaemic stroke in men with type 2 diabetes mellitus.
Topics: Aged; Biomarkers; Diabetes Mellitus, Type 2; Gonadal Steroid Hormones; Humans; Hypogonadism; Male; Middle Aged; Russia; Stroke; Testosterone | 2020 |
Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Disease Progression; Humans; Hypogonadism; Male; Middle Aged; Prediabetic State; Registries; Testosterone; Triglycerides | 2019 |
The use of drugs Impaza and Nebido in the treatment of erectile dysfunction in patients with type 2 diabetes mellitus of reproductive age.
Topics: Adolescent; Adult; Androgens; Antibodies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Middle Aged; Penile Erection; Surveys and Questionnaires; Testosterone; Treatment Outcome; Young Adult | 2013 |
Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.
Topics: Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Erectile Dysfunction; Glycated Hemoglobin; Hormone Replacement Therapy; Humans; Hypoglycemic Agents; Hypogonadism; Incretins; Liraglutide; Male; Metformin; Middle Aged; Obesity; Penile Erection; Retrospective Studies; Risk Reduction Behavior; Testosterone; Time Factors; Treatment Outcome; Weight Loss | 2015 |
[Androgenic deficit and its treatment in stroke male patients with diabetes mellitus type II].
Topics: Aged; Androgens; Diabetes Mellitus, Type 2; Hormone Replacement Therapy; Humans; Male; Middle Aged; Stroke; Testosterone | 2011 |
Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone.
Topics: Aged; Case-Control Studies; Diabetes Mellitus, Type 2; Erectile Dysfunction; Humans; Male; Middle Aged; Piperazines; Purines; Sildenafil Citrate; Sulfones; Testosterone; Testosterone Congeners; Treatment Failure; Vasodilator Agents | 2003 |